Literature DB >> 573694

Interactions between serotonergic and dopaminergic systems in rat brain demonstrated by small unilateral lesions of the raphe nuclei.

N M Nicolaou, M Garcia-Munoz, G W Arbuthnott, D Eccleston.   

Abstract

Unilateral lesions in the dorsal raphe (DR) resulted in decreased concentrations of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid and increases in homovanillic acid and 3,4-dihydroxyphenylacetic acid in the ipsilateral substantia nigra (SN). Unilateral lesions in the median raphe (MR) caused similar biochemical changes in the corpus striatim (CS). Apomorphine and amphetamine caused turning behaviour in the lesiond animals which was ipsiversive after DR lesions but contraversive after MR damage. The animals turned in the opposite direction to that induced by these drugs after treatment with 5-methoxy-N,N-dimethyltryptamine and in the same direction after treatment with phenelzine plus L-tryptophan. All the drug-induced turning behaviour was blocked by haloperidol. The turning induced by 5-methoxy-N,N-dimethyltryptamine and in the same direction after treatment with phenelzine plus L-tryptophan. All the drug-induced turning behaviour was blocked by haloperidol. The turning induced by 5-methoxy-N,N-dimethyltryptamine was blocked by methysergide. This work suggested that the DR and MR nuclei send projections differentially to SN and CS respectively. These projections may exert a tonically active inhibition of dopamine metabolism in their respective terminal areas.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 573694     DOI: 10.1016/0014-2999(79)90492-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

2.  The effect of raphé nuclei lesions on striatal tyramine concentration and dopamine turnover in the rat.

Authors:  A V Juorio; A J Greenshaw
Journal:  Neurochem Res       Date:  1986-05       Impact factor: 3.996

3.  Effects of thalamic lesion on the bilateral regulation of serotoninergic transmission in rat basal ganglia.

Authors:  D Becquet; M Faudon; F Hery
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

4.  The Yawning elicited by alpha-melanocyte-stimulating hormone involves serotonergic-dopaminergic-cholinergic neuron link in rats.

Authors:  K Yamada; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

5.  The effects of intraventricular 6-hydroxydopamine and 5,6-dihydroxytryptamine on morphine induced locomotor stimulation.

Authors:  P Slater; C Blundell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-07       Impact factor: 3.000

Review 6.  Clozapine: new research on efficacy and mechanism of action.

Authors:  H Y Meltzer; B Bastani; L Ramirez; S Matsubara
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

7.  The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo.

Authors:  H Nissbrandt; N Waters; S Hjorth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

8.  Uptake of 5-hydroxytryptamine in the catecholamine containing areas of the hypothalamus of the rat after treatment with phenelzine and tryptophan.

Authors:  G W Arbuthnott; D Eccleston; I Laszlo; N Nicolaou
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

9.  Involvement of a central dopaminergic system in 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in rats with lesions of the dorsal raphé nuclei.

Authors:  T P Blackburn; B Cox; T F Lee
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  8-OH-DPAT elicits gnawing, and eating of solid but not liquid foods.

Authors:  P J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.